Avantor, INC Schedule 13G passive stakes

Vanguard Capital Management reports beneficial ownership of 35,802,263 shares, representing 5.29% of Avantor Inc.'s common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G for Avantor Inc., reporting 0% beneficial ownership following an internal realignment where subsidiaries will now report separately.

T. Rowe Price Investment Management, Inc. has filed an Amendment No. 7 to Schedule 13G, disclosing a 4.8% beneficial ownership stake in Avantor Inc.

BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a continued beneficial ownership of 8.7% of Avantor, Inc.'s common stock as of September 30, 2025.

T. Rowe Price Investment Management, Inc. has disclosed an 8.3% beneficial ownership stake in Avantor Inc., holding over 56.5 million shares of common stock.

Dodge & Cox, an investment adviser, has disclosed a significant beneficial ownership stake of 17.2% in Avantor, Inc. common stock as of June 30, 2025.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a 6.1% beneficial ownership stake in life sciences company Avantor Inc. as of December 31, 2024.

Investment advisor Dodge & Cox has filed an amended Schedule 13G, revealing a substantial 14.6% beneficial ownership stake in Avantor, Inc. as of December 31, 2024.